Acquiring and Assessing Skills in Endoscopic Surgery

Objectives : At the conclusion of this session, participants should be able to: a) describe the available methods of assessment of endoscopic surgery; b) discuss the metrics which can be measured to determine competency in endoscopic surgery; and c) discuss a validated curriculum for endoscopic surgery.

______________________

Using Validated Clinical Measures to Assess Endoscopic Skills Acquired Through Simulation

Speaker(s) : Gerald Fried, MD, Montreal, Canada


______________________

Models for Learning Endoscopic and Flexible Endoscopic Skills

Speaker(s) : Brian Dunkin, MD, Houston, TX


______________________

Learning and Maintaining Skills in Colonoscopy

Speaker(s) : Eric Weiss, MD,Weston, FL


______________________

Fundamentals of Endoscopic Surgery

Speaker(s) : Jeffrey Marks, MD, Cleveland, OH


______________________

The Role of Simulation in Endoscopic Surgery

Speaker(s) : Shawn Tsuda, MD, Las Vegas, NV

Benign I

Objectives : At the conclusion of this session, participants should be able to: (10) discuss the ability of medical clinicians to accurately diagnose common anorectal pathology; understand the need to develop educational programs for medical professionals in the accurate diagnosis of common anorectal pathology; (11) assess the value of a Hanley technique in the treatment of complex horseshoe fistulae; (12) understand the clinical difficulties in dealing with transsphincteric fistula; familiar with surgical options for dealing with trans-sphincteric fistula; (13) know the new technique for treatment of fistula-in-ano; (14) assess the efficacy of the Surgisis Plug and understand how to put it in with better results; (15) familiar with a simple and safe haemorrhoidopexy procedure to treat third degree haemorrhoids with good results; (16) correctly use the Transanal Hemorrhoidal Dearterialization (THD) in the treatment of various degrees of hemorrhoids; evaluate safety and effectiveness of THD therapy; (17) learn patient satisfaction and outcomes following Stapled Transanal Rectal Resection (STARR procedure) for obstructive defecation syndrome; and (18) discuss the role of Botox in the treatment of chronic anal fissure; discuss the healing and recurrence rates of anal fissure after Botox injection; discuss some factors affecting recurrence and healing after Botox injection for anal fissure.

______________________

A Prospective Analysis of Clinician Accuracy in the Diagnosis of Benign Anorectal Pathology: Comparison Across Specialties and Years of Experience

Speaker(s) : D.B. Chessin, S.R. Gorfine, A. Grucela, S. Khaitov, H. Salinas, R.M. Steinhagen


______________________

Modified Hanley Procedure for Management of Complex Horseshoe Fistulae

Speaker(s) : L. Browder, A.M. Kaiser, S. Sweet


______________________

Ligation of the Intersphincteric Fistula Tract: An Effective New Technique for Complex Fistulae

Speaker(s) : J.I. Bleier, S. Goldberg, H. Moloo


______________________

The Ligation of Intersphincteric Fistula Tract for Fistula-in-Ano: Sphincter Saving Technique

Speaker(s) : N. Amri, M.N. Azmi, A. Shanwani


______________________

Follow-Up of Collagen Plug for Anorectal Fistulas

Speaker(s) : S. Khaitov, A.J. Ky, E.C. Ly, E. Steinhagen


______________________

Trans Anal Open Hemorrhoidopexy

Speaker(s) : C.G. Baeten, B. Govaert, C. Helmes, F. Pakravan


______________________

Transanal Hemorrhoidal Dearterialization: An Effective Mini-Invasive Therapeutic Approach to Hemorrhoids

Speaker(s) : G.B. Doglietto, L. Donisi, F. Litta, A. Parello, C. Ratto


______________________

Patient Satisfaction and Outcomes Following Stapled Transanal Rectal Resection for Obstructive Defecation Syndrome

Speaker(s) : N. Bhoot, E. Haas, T.B. Pickron


______________________

Chronic Anal Fissure: The High-Dose Botox Experience

Speaker(s) : S.M. Barone, L. Kondylis, P.D. Kondylis, J. Park, J.C. Reilly

Benign II

Objectives : At the conclusion of this session, participants should be able to: (40) evaluate the outcome of SNS for constipation and future research direction; (41) appreciate the utility of ESGN construction for restoration of gastrointestinal continuity in patients motivated to avoid permanent stoma formation; (42) select treatment for fecal incontinence in presence of sphincter lesion, betweeen Sphincteroplasty and Sacral Nerve Stimulation; (43) use patient charecteristics to predict outcome in Sacral Nerve Stimulation therapy for fecal incontinence; (44) compare advantages in postoperative outcomes of elderly patients (pts) (> 70 yo) undergoing Altemeier procedure (ALT) vs. laparoscopic rectopexy (RPX) for full-thickness rectal prolapse(RP); (45) understand the role of aminocaproic acid in the management of massive lower gastrointestinal hemorrhage; and (46) understand role of utilization and the efficacy mesenteric embolization in treatment of lower gastrointestinal bleeding.

______________________

Sacral Nerve Stimulation for Constipation: Loss of Efficacy and Re-Operations

Speaker(s) : S. Buntzen, S. Laurberg, L. Lundby, Y. Maeda


______________________

Electrically Stimulated Gracilis Neosphincter Construction for End Stage Fecal Incontinence: Evaluation of Long-Term Functional Outcome

Speaker(s) : C. Bhan, D.J. Boyle, J. Murphy, J. Saunders, N.S. Williams


______________________

Sacral Nerve Stimulation is a Valid Therapy in Fecal Incontinent Patients with Sphincter Lesion, When Compared to Sphincter Repair

Speaker(s) : G.B. Doglietto, L. Donisi, F. Litta, A. Parello, C. Ratto


______________________

Predictive Factors for Subchronic Test Stimulation Outcome in Sacral Nerve Modulation for the Treatment of Fecal Incontinence

Speaker(s) : C.G. Baeten, B. Govaert, W.G. van Gemert


______________________

What Is Optimal Treatment of Rectal Prolapse in Elderly Patients: Altemeier Procedure vs. Laparoscopic Rectopexy?

Speaker(s) : D.L. Feingold, M. Gedeon, S.W. Lee, A. Li, J.W. Milsom, O. Oliveira, T. Sonoda, S.L. Stein, K.J. Trencheva


______________________

The Role of Aminocaproic Acid in the Management of Massive Lower Gastrointestinal Hemorrhage

Speaker(s) : S. Clark, P. Cole, G. Dunn


______________________

Mesenteric Embolization: A Safe and Efficacious Treatment Modality of Lower Gastrointestinal Hemorrhage

Speaker(s) : D. Beck, T. Hicks, D. Margolin, P. Rider, A. Timmcke, C. Whitlow

Benign III

Objectives : At the conclusion of this session, participants should be able to: (54) identify patients that are at high risk for failing outpatient management of acute diverticulitis; (55) analyze the differences in presentation of diverticulitis in young populations; indentify computed tomography findings that are predictive of severe diverticular disease; (56) predict the risk of conservative treatment failure of acute left colonic diverticulitis; elaborate a treatment plan of acute left colonic diverticulitis; and define the severity of diverticulits episode in research protocols; (57) identify the benefits of fast track protocols for laparoscopic colecotmy; define a fast track protocol; (58) describe differences between civilian and combat colon injuries; compare early complication rates for primary repair versus diversion in the combat setting and in the context of available civilian literature; understand the management options for colon injuries including in the damage control setting; and (59) understand and appreciate data demonstrating outcomes after emergency colon resection with and without an anastomosis.

______________________

Outpatient Treatment of Acute Diverticulitis: Rates, Predictors of Failure

Speaker(s) : M.A. Abbas, R.J. Burchette, R.R. Cannom, V.Y. Chiu, D.A. Etzioni, P.I. Haigh


______________________

Diverticulitis: Does Age Predict Complicated Disease?

Speaker(s) : J.F. Hall, P.W. Marcello, R. Ricciardi, P.L. Roberts, J.M. Sampson, C. Scheirey, D. Schoetz, C. Wald


______________________

Risk Assessment of Conservative Treatment Failure in Acute Left Colonic Diverticulitis

Speaker(s) : J.M. Calmes, N. Demartines, A. Denys, N. Kotzampassakis, O. Pittet, S. Schmidt


______________________

A Fast Track Recovery Protocol Improves Outcomes in Elective Laparoscopic Colectomy for Diverticulitis

Speaker(s) : H.K. Chua, R.R. Cima, E.J. Dozois, D.W. Larson, J.H. Pemberton, J.G. Touzios


______________________

Management of Colon Injuries in the Combat Theater

Speaker(s) : D. Cho, S.F. Flaherty, D. Herzig, L.N. Kiraly, M.A. Schreiber


______________________

Anastomosis in Emergency Colon Surgery: A Large Propensity Score Match Analysis

Speaker(s) : C.M. Friel, T.L. Hedrick, R.G. Sawyer, B.R Swenson

Core Subject Update

Objectives : At the conclusion of this session, participants should be able to: a) understand an evidence-basedapproach to the management of anorectal fistula disease and become familiar with less invasive approaches to the treatment of anorectal fistula; b) understand the epidemiology, etiologies and impact of fecal incontinence as well as the workup, differentiate between various treatment modalities for fecal incontinence; c) discuss the etiology, presentation and treatment of colitidies not associated with IBD, such as infectious and non-infectious colitidies, collagenous colitis, solitary rectal ulcer syndrome, medication related colitis and other more rare colitidies; d) understand the pathophysiology of acute diverticulitis, the evolving indications for surgery and the evolving options for surgical procedures; e) understand the most recent trials of adjuvant therapy for colon cancer, the mechanisms of action of emerging agents in adjuvant therapy for colon cancer and gain an awareness of growing controversies/emerging treatment paradigms in colon cancer.

______________________

Fistulas/Abscess

Speaker(s) : Bradley Champagne, MD, Cleveland, OH


______________________

Fecal Incontinence

Speaker(s) : Andreas Kaiser, MD, Los Angeles, CA


______________________

Other Colitidies

Speaker(s) : Farshid Araghizadeh, MD, Dallas, TX


______________________

Diverticulitis

Speaker(s) : M. Shane McNevin, MD, Spokane,WA


______________________

Colon Cancer (Controversies in Surgical/Medical Therapy)

Speaker(s) : Howard Ross, MD, Red Bank, NJ

Ernestine Hambrick Lectureship

Objectives :

______________________

Innovative Management of Rectal Cancer

Speaker(s) : Angelita Habr-Gama, MD, Sao Paulo, Brazil

Harry E. Bacon Lectureship

Objectives :

______________________

Challenges and Opportunities Facing American Graduate Medical Education in 2009

Speaker(s) : Thomas J. Nasca, MD, Chicago, IL

Inflammatory Bowel Disease

Objectives : At the conclusion of this session, participants should be able to: (25) understand the importance of distinguishing between surgical complications following IPAA and Crohn's disease; (26) assess the prognostic significance of backwash ileitis on the outcome of ileal pouch-anal anastomosis in patients with inflammatory bowel disease; (27) understand the long term outcome of patients with a kock pouch; (28) appreciate the gender specific diffences in outcome for patients with inflammatory bowel disease who undergo proctectomy; (29) discuss the outcome and long-term function for patients undergoing restorative proctocolectomy for Crohn's disease; compare the long-term functional outcome between patients with Crohn's disease and ulcerative colitis undergoing a restorative proctocolectomy; and (30) describe healthcare resource utilization before and after surgery for ulcerative colitis; discuss differences in healthcare resource utilization between different surgical procedures for ulcerative colitis.

______________________

Technical Complications After Ileal Pouch-Anal Anastomosis May Be Misinterpreted as Crohns Disease

Speaker(s) : V.W. Fazio, K. Garrett, R.P. Kiran, H.T. Kirat, F. Remzi, B. Shen


______________________

A Prospective Analysis of the Outcome of Ileal Pouch-Anal Anastomosis in Inflammatory Bowel Disease Patients with Backwash Ileitis

Speaker(s) : P. Fleshner, Z, Murrell, E. White


______________________

Preservation of the Kock Pouch is High in Long-Term Follow-Up

Speaker(s) : Z. Cohen, S. Cowie, S. Forbes, R. McLeod, B. OConner, C. Victor


______________________

Gender-Specific Differences in Pelvic Organ Function After Proctectomy for Inflammatory Bowel Disease

Speaker(s) : K. DelRosario, A. DelRosario, S.L. Hart, J. Lee, M.G. Varma, J. Wang


______________________

Outcome and Long-Term Function of Restorative Proctocolectomy for Crohns Disease: Comparison to Patients with Ulcerative Colitis

Speaker(s) : J.J. Bauer, D.B. Chessin, S.R. Gorfine, A. Grucela


______________________

Healthcare Resource Utilization and Associated Costs Before and After Surgery for Ulcerative Colitis: A Population-Based Study in Olmsted County, Minnesota

Speaker(s) : E. Barnitt, R.R. Cima, S.D. Holubar, E.V. Loftus, K. Long, J.H. Pemberton, B.G. Wolff

Maintenance of Certification

Objectives : At the conclusion of this session, participants should be able to: a) describe the basic principles that led to the transition from re-certification to Maintenance of Certification; b) plan for participation in the Maintenance of Certification process by better understanding the requirements set forth by the ABCRS; and c) describe the key components of Maintenance of Certification.

______________________

Current Status of Maintenance of Certification

Speaker(s) : Martin Luchtefeld, MD, Grand Rapids, MI


Click the PDF icon for the presentation download.
______________________

Maintenance of Certification: The Canadian Way

Speaker(s) : W. Donald Buie, MD, Calgary, AB, Canada


Click the PDF icon for the presentation download
______________________

An Overview of MOC and a Look into the Future

Speaker(s) : Kevin B. Weiss, MD, MPH, Evanston, IL


Click the PDF icon for the presentation download

Mathews Oration

Objectives :

______________________

If an Operation Can't Cure You, What Can I Do?

Speaker(s) : Ira Kodner, MD, St. Louis, MO

Memorial Lectureship Honoring Dr. Alejandro F. Castro

Objectives :

______________________

Saving the Sphincter: A Story of Surgical Evolution

Speaker(s) : Richard Billingham, MD, Seattle, WA

Neoplasia I

Objectives : At the conclusion of this session, participants should be able to: (1) analyze the impact of the interval between completion of neoadjuvant chemoradiation and surgery on tumor downstaging, oncologic outcomes and perioperative morbidity/mortality; (2) analyze the impact of the addition of chemotherapy during the resting period after CRT on complete response rates for distal rectal cancer; (3) analyze the chance of durable tumor remission after neoadjvant radiochemotherapy in rectal cancer; understand the role of surgery in different stages of rectal cancer; (4) understand the rationale for using brachytherapy as a neoadjuvant radiotherapy modality in rectal cancer treatment; (5) differentiate outcomes of transanal endoscopic microsurgery in benign and malignant rectal tumors; identify situations in which TEM may be useful; (6) understand that local excision after a good response to chemoradiation for rectal cancer is still investigational; developments in MR technique and lymph node specific MR contrast agents could produce tools that help in selecting patients for this controversial approach; (7) know the basic principles and indications of transanal endoscopic microsurgery (TEM); manage local recurrences after TEM for pT1 rectal cancer; (8) analyze the feasibility of laparoscopic surgery in rectal cancer; compare the long term results with open surgery; and (9) know that anastomosis higher than 4cm to anal verge was comparably safe and defunctioning stoma can be selective.

______________________

Neoadjuvant Therapy for Rectal Cancer: Does The Interval Between Chemoradiation and Surgery Matter?

Speaker(s) : A. da Luz Moreira, V.W. Fazio, D. Geisler, L. F. Lobato


______________________

Can We Increase the Rates of Complete Response for Distal Rectal Cancer? Results of a Prospective Study Using Additional Chemotherapy During the Resting Period of Neoadjuvant CRT

Speaker(s) : P. Aguilar, J. Gama-Rodrigues, A. Habr-Gama, W. Nadalin, R.O. Perez, I. Proscurshim, J. Sabbaga


______________________

Complete Remission After Neoadjuvant Radiochemotherapy in Rectal Cancer: Radical Surgery Or "Wait and See"?

Speaker(s) : W. Hohenberger, H.P. Kessler, S. Merkel


______________________

Neoadjuvant High Dose-Rate Endorectal Brachytherapy in the Era of Total Mesorectal Excision for Patients with Rectal Cancer: Ten Year Follow-Up

Speaker(s) : D. Anderson, G. Artho, G. Bourdon, P. Charlebois, S. Devic, F. Letellier, A.S. Liberman, J. Parent, C. Richard, B. Stein, T. Vuong, K. Waschke


______________________

Transanal Endoscopic Microsurgery Resection of Rectal Tumors: Outcomes and Recommendations

Speaker(s) : D. Christoforidis, C.O. Finne, R.D. Madoff, A.F. Mellgren, J. Nordenstam, B.M. Tsai


______________________

Can MRI After Chemoradiation for Rectal Cancer Select Patients with a Good Response for Local Excision?

Speaker(s) : G.L. Beets, R.G. Beets-Tan, S.M. Engelen, R. Jansen, J. Konsten, M.J. Lahaye, G. Lammering, J.W. Leijtens, R.M. van Dam, C.J. van de Velde


______________________

Salvage Treatment of Recurrences After Transanal Endoscopic Microsurgery

Speaker(s) : I.M. Dawson, E.J. de Graaf, J.H. de Wilt, F.T. Ferenschild, G.W. Tetteroo

Neoplasia II

Objectives : At the conclusion of this session, participants should be able to: (31) recognize the influence of individual gene expression patterns on rectal cancer recurrence; appreciate the possibility of individualizing patient care based on tumor gene expression; (32) examine the effect of TNFon p53 and PUMA; analyze the potential role of TNF in inflammatory bowel disease-associated carcinogenesis; (33) comprehend the basic science underlying current SIRT1 and eIF4E research and its clinical implications; analyze the difference in clinical outcomes of colon cancer patients who express SIRT1 and eIF4E; (34) recognize that genetic and epigenetic differences between primary tumors and lymph node metastases exist; understand clinical implications of genetic and epigenetic differences between primary tumors and lymph nodes as they relate to treatment decisions and outcomes; (35) develop a plan of management for an individual who are at high risk of lymph node metastasis; (36) know features of CTA genes in predicting liver metastasis of CRC; (37) identify the role of SLN mapping in rectal cancer; identify the affect of neoadjuvant treatment in nodal harvest in rectal cancer; (38) implement ex-vivo methylene blue injection of the inferior mesenteric artery as a method to improve the lymph node harvest and eliminate pathologist variability in rectal cancer staging; and (39) know how fat clearance greatly increased lymph nodes retrieval especially for small lymph nodes.

______________________

Gene Signature Predicts Early Stage Rectal Cancer Recurrence: A Step Toward Individualized Treatment Decisions

Speaker(s) : J.M. Church, K. DeJulius, H. Ishwaran, M.F. Kalady, I.C. Lavery, J.A. Sanchez


______________________

Effects of TNFon P53 and PUMA in Colorectal Cancer

Speaker(s) : R.B. Irby, D.M. Pastor, L.S. Poritz


______________________

SIRT1 and eIF4E in Colon Cancer Outcome

Speaker(s) : Q. Chu, P.A. Cole, B.D. Li, W. Pruitt, K. Pruitt, M.H. Smith


______________________

The Truth About Advanced Stage Colorectal Cancer: What the Primary Lesions Don't Tell You

Speaker(s) : J.M. Church, M.F. Kalady, X. Liu, C. Messick


______________________

Comparison of Cancer Testis Antigen Expression in Colorectal Cancer With or Without Liver Metastasis

Speaker(s) : G.Z. Chen, J. Gu


______________________

Ex Vivo Sentinel Lymph Node Mapping in Patients Undergoing Proctectomy for Rectal Cancer

Speaker(s) : E. Bailey, E.H. Birnbaum, K.R. Finan, J.W. Fleshman, J.L. Lewis, M. Mutch


______________________

Injecting Methlyene Blue into the Inferior Mesenteric Artery Assures an Adequate Nodal Harvest and Eliminates Pathologist Variability in Rectal Cancer Nodal Staging

Speaker(s) : M. Anthuber, H. Arnholdt, T.G. Kerwel, B. Markl, J. Spatz, K. Wunsch

Neoplasia III

Objectives : At the conclusion of this session, participants should be able to: (47) analyze the differences in colon cancer rates, stage at diagnosis, and treatments for black and white patients in an equal access health care system; (48) understand the 2008 U.S. Preventative Services Task force Recommendations for Colorectal Cancer Screening; understand the changes in age at diagnosis distribution for colorectal cancer over time at the authors' institution; understand how the 2008 USPSTF recommendations for colorectal cancer screening are called into question by the study's findings; (49) discuss the rate of pCR post chemoradiotherpay for rectal cancer. Discuss the prevalence of metastatic lymph nodes in patients with a complete mural response to chemoradiotherapy; (50) analyze the differences in survival and predictors of resectability of patients presenting with rectal cancer and liver metastases; (51) learn safe practice in stenting of colonic obstruction; (52) appreciate a newly noticed potential overlap between Hereditary Nonpolyposis Colorectal Cancer (HNPCC) and Hyperplastic Polyposis (HPS) Syndrome; appreciate the possibility that HPS may be under diagnosed, and that a subset of HNPCC and hereditary colon cancer is misdiagnosed; and (53) select patients with carcinoma of the anal canal for inguinal sentinel node biopsy; realize the possible benefits of this technique; develop an individualized treatment for patients with carcinoma of the anal canal.

______________________

Effect of Race On Colon Cancer Care in the Department of Defense Health Care System

Speaker(s) : K.G. Davis, L.J. Hofmann, S. Lee, B.E. Waddell


______________________

Evaluating the Age Distribution of Patients with Colorectal Cancer: Are the U.S. Preventative Services Task force Guidelines for Colorectal Cancer Screening Appropriate?

Speaker(s) : J.K. Shellnut, H.J. Wasvary


______________________

Downstaging Following CRT for Locally Advanced Rectal Cancer: Is There More (Tumor) than Meets the Eye?

Speaker(s) : D. Dietz, I.C. Lavery, L.F. Lobato, E.D. Mignanelli, L. Stocchi


______________________

Palliative Resection of the Primary Lesion in Stage IV Rectal Cancer Prolongs Survival

Speaker(s) : E. Birnbaum, C. Cellini, J. Fleshman, S. Hunt, A. Lin, M. Mutch


______________________

Combined Radiological and Endoscopic Approach has a Higher Success Rate in Colonic Stenting

Speaker(s) : F. Bergin, H. Gallagher, J. Graham, J. Hanson, S. Plusa, D. Richardson, A. Venkatasubramaniam, N. Wong


______________________

Is the Phenotype Mixed or Mistaken? Hyperplastic Polyposis Syndrome and Hereditary Non Polyposis Colorectal Cancer

Speaker(s) : J.M. Church, S. Fay, A.M. Jarrar, M.F. Kalady


______________________

Sentinel Node Biopsy in Squamous-Cell Carcinoma of the Anal Canal

Speaker(s) : C. Canevari, M. Carvello, P. De Nardi, P. Passoni, N. Slim, C. Staudacher

Norman Nigro Research Lectureship

Objectives :

______________________

Conflict of Interest Interactions Between Physician Researchers and Industry

Speaker(s) : Erin Reilly Lewis, Indianapolis, IN

Outcomes I

Objectives : At the conclusion of this session, participants should be able to: (19) validate potential predictors of surgical wound infection after colon and rectal surgery; (20) analyze the impact of SCIP (Surgical Care Improvement Project) health care practices to prevent surgical site infection after elective colorectal resections; (21) understand the importance of decreasing surgical site infections; critically analyze the role of the glycemic response in relation to the development of surgical site infections realizing the numerous other factors that can contribute to this problem; (22) understand the components of the Surgical Care Improvement Project; analyze how these components, and other potential factors, impact development of surgical site infections; recognize the importance of careful assessment of care measures before implementation, and the possible clinical and economical results of such implementation; (23) understand the risk factors for perineal wound complications after APR for rectal cancer; the effect of preoperative neoadjuvant therapy on perineal wound healing; and (24) understand outcomes associated with pseudomembranous colitis in patients who have undergone colonic resection and factors associated with its occurrence.

______________________

Validation of Risk Index Category as a Predictor of Surgical Site Infection in Colorectal Patients

Speaker(s) : J.H. Baek, J. Garcia-Aguilar, L. Gibbs, L.A. Indorf, E. Kim, C. Pastor, M.G. Varma


______________________

An Increase in Compliance with SCIP Measures Does Not Prevent Surgical Site Infection in Colorectal Surgery

Speaker(s) : A. Artinyan, J.H. Baek, J. Garcia-Aguilar, L. Gibbs, L.A. Indorf, E. Kim, C. Pastor, M.G. Varma


______________________

Does Absolute Glycemic Response or the Variability of Glycemic Response Affect Surgical Site Infection Rates?

Speaker(s) : T. Asgeirsson, N. Dujovny, K. El-Badawi, R. Hoedema, D. Kim, M. Luchtefeld, A. Mahmood, A.J. Senagore, H. Slay


______________________

Does SCIP Compliance Make Surgical Site Infection a Never Event?

Speaker(s) : T. Asgeirsson, N. Dujovny, K. El-Badawi, R. Hoedema, D. Kim, M. Luchtefeld, A. Mahmood, A.J. Senagore, H. Slay


______________________

Factors Associated with Perineal Wound Complications After Abdominoperineal Resection for Cancer of the Rectum

Speaker(s) : G. El-Gazzaz, R.P. Kiran, I.C. Lavery


______________________

The Morbidity of Clostridium Difficile Infection Following Elective Colonic Resection-Results from a National Population Database

Speaker(s) : K. Lesperance, M. Spencer, S.R. Steele

Outcomes II

Objectives : At the conclusion of this session, participants should be able to: (60) assess the responsiveness of general surgery residents to simulated laparoscopic sigmoidectomy training; develop a plan for simulated laparoscopic sigmoidectomy training for residents; (61) understand patterns of laparoscopic colectomy training and impact of training on comfort level for graduating colorectal residents; (62) understand the use of esophageal doppler for guiding fluid administration and the relative benefits of various fluid strategies; (63) understand implications of 'fast track' programs on hemodynAmics and renal function; (64) understand both patient and hospital factors associated with sphincter preserving surgery for rectal cancer; describe the increased adoption of sphincter preserving techniques over time across the U. S.; discuss differences in rates of sphincter preserving surgery across hospitals of different volume, location, and teaching status; describe implications of hospital variations in delivery of care for rectal cancer patients across the U. S.; (65) understand the effect of coloanal anastomosis and abdominoperianal resection on patients΄ quality of life; learn to improve counseling of these patients; (66) better understand the outcomes of octogenarians and nonagenarians following colorectal cancer resection in a large population cohort; (67) understand the prevalence and significance of post-operative ileus in our health system and realize the importance of prophyllaxis/treatment in controlling this morbidity and the costs associated with it; and (68) understand a potential new therapeutic agent for the management of postoperative ileus.

______________________

Simulated Laparoscopic Sigmoidectomy Training: Responsiveness of Surgery Residents

Speaker(s) : H. Ahn, R. Bergamaschi, R. Essani, A. McLarty, L. Merriam, R. Scriven


______________________

ASCRS Residency Training After the Cost Trial: Are our Fellows Primed to Perform Laparoscopic Colectomy?

Speaker(s) : B.J. Champagne, S.L. Stein, J.J. Stulberg


______________________

Fluid Management for Laparoscopic Colectomy: A Prospective Randomized Assessment of Goal Directed Administration of Balanced Salt Solution or Hetastarch Coupled with an Enhanced Recovery Program

Speaker(s) : N. Dujovny, T.A. Emery, R. Hoedema, D. Kim, M. Luchtefeld, A.J. Senagore, H. Slay


______________________

Impact of Fast Track Surgery on Hemodynamics and Renal Function: Results of a Controlled Randomized Trial

Speaker(s) : P.A. Clavien, N. Demartines, M. Hubner, S. Muller, M.P. Zalunardo


______________________

Hospital Based Factors in Sphincter Preserving Surgery for Rectal Cancer

Speaker(s) : S. Finlayson, J.A. Kemp, I.M. Paquette


______________________

Quality of Life After Coloanal Anastomosis and Abdominoperineal Resection for Low Rectal Cancers. Sphincter Preservation vs. Quality of Life

Speaker(s) : R.R. Cima, E.J. Dozois, R.E. Gullerud, I. Hassan, M.S. Kasparek, D.W. Larson, D.R. Larson, J.H. Pemberton, B.G. Wolff


______________________

Caring for Octogenarian and Nonagenarian Colorectal Cancer Patients - What Should Our Standards and Expectations Be?

Speaker(s) : C.Y. Ko, H. Kunitake, D.S. Zingmond


______________________

Post-Operative Ileus: It Costs More Than You Expect

Speaker(s) : T. Asgeirsson, J. Barletta, N. Dujovny, K. El-Badawi, R. Hoedema, D. Kim, M. Luchtefeld, A. Mahmood, A.J. Senagore, H. Slay


______________________

Ghrelin Agonist TZP-101 for Management of Postoperative Ileus After Segmental Colectomy: A Multinational, Randomized, Dose-Ranging, Double-Blind, Placebo-Controlled Study

Speaker(s) : S. Berry, P. Charlton, P. Fleshner, G. Kosutic, J.C. Pezzullo, I. Popescu, G.V. Rao, A.J. Senagore, S. Varshney

Parviz Kamangar Humanities in Surgery Lectureship

Objectives :

______________________

Emotional Management and the Ethics of Medical Decision Making

Speaker(s) : Chris Feudtner, MD, PhD, Philadelphia, PA

Presidential Address

Objectives :

______________________

It is the Unknown Unknowns that Really Matter

Speaker(s) : Anthony J. Senagore, MD, Grand Rapids, MI

Research Foundation Update

Objectives : Dr. Guillem will present an overview of recent activities of the Research Foundation including: fund raising efforts, the fostering of interactions with the National Institutes of Health and the development of broader funding opportunities for those who conduct clinical and basic research on diseases of the colon, rectum and anus.

______________________

Research Foundation Update

Speaker(s) : Josι Guillem, MD, New York, NY

Single Port Minimally Invasive Surgery / NOTES

Objectives : At the conclusion of this session, participants should be able to: a) describe the current status of NOTES in colon and rectal surgery; b) describe the current status of single port laparoscopy in colon and rectal surgery; c) discuss endolumenal surgery and its applications in colon and rectal surgery; and d) discuss how these three surgical innovations could influence the future of colon and rectal surgery.

______________________

NOTES in Colorectal Surgery – Experimental Models

Speaker(s) : Mark Whiteford, MD, Portland, OR


______________________

NOTES Colectomy: Current Experience in Humans

Speaker(s) : Antonio Lacy, MD, Barcelona, Spain


______________________

Single Port Laparoscopy – Here to Stay?

Speaker(s) : Feza Remzi, MD, Cleveland, OH


______________________

Endoluminal Surgery: Combined Laparoscopy and Endoscopy

Speaker(s) : Sang Lee, MD, New York, NY

Symposium: Laparoscopic Colorectal Surgery: Nuts, Bolts and New Tools for Your Toolbox

Objectives : At the conclusion of this session, participants should be able to: a) understand various methods of colon mobilization and vascular control; b) understand the special challenges and techniques associated with pelvic dissection; and c) have a better understanding of fundamentals of reoperative intestinal surgery.

______________________

OR Set up and Patient Positioning

Speaker(s) : Jon Vogel, MD, Cleveland, OH


______________________

Right Colon Vascular Control Using Mechanical Devices: Clips and on Staplers

Speaker(s) : Robin Boushey, MD, Ottawa, Canada


______________________

Left Colon Vascular Control Using Energy Devices: Ultrasonic and Bipolar Devices

Speaker(s) : Alan Herline, MD, Nashville, TN


______________________

Left Ureter Hide and Seek

Speaker(s) : David Rivadeneira, MD, Smithtown, NY


______________________

Controlling the Out-of-Control: Hemorrhage

Speaker(s) : Sharon Stein, MD, New York, NY


______________________

Hepatic Flexure: Antegrade Starting at Ascending Colon

Speaker(s) : Bradford Sklow, MD, Salt Lake City, UT


______________________

Hepatic Flexure: Retrograde Starting at the Transverse Colon

Speaker(s) : Kirk Ludwig, MD, Milwaukee, WI


______________________

Splenic Flexure: Retrograde Starting at Descending Colon

Speaker(s) : Tonia Young-Fadok, MD, Phoenix, AZ


______________________

Splenic Flexure: Antegrade Starting at Transverse Colon

Speaker(s) : John Marks, MD,Wynnewood, PA


______________________

Retracting the Uterus:Transabdominal Techniques

Speaker(s) : Nadav Dujovny, MD, Grand Rapids, MI


______________________

Laparoscopic TME: Dissection and Mobilization

Speaker(s) : David Jayne, MD, Leeds, United Kingdom


______________________

Laparoscopic TME: The Ideal First Assistant

Speaker(s) : George Chang, MD, Houston, TX


______________________

Laparoscopic TME: Deep Pelvic Exposure, Dissection and Division

Speaker(s) : Eric Weiss, MD,Weston, FL


______________________

Laparoscopic TME: How the Robot Makes it Better

Speaker(s) : Sonia Ramamoorthy, MD, San Diego, CA


______________________

Laparoscopic TME: Restoring Continuity

Speaker(s) : Bradley Champagne, MD, Cleveland, OH


______________________

Laparoscopic Management of Small Bowel Obstruction

Speaker(s) : Mark Whiteford, MD, Portland, OR


______________________

Laparoscopic Parastomal Hernia Repair

Speaker(s) : Jonathan Efron, MD, Phoenix, AZ


______________________

Laparoscopic Assisted Colonoscopic Polypectomy

Speaker(s) : Sang Lee, MD, New York, NY


______________________

Laparoscopic Resection-Rectopexy for Prolapse

Speaker(s) : Madhulika Varma, MD, San Francisco, CA


______________________

Laparoscopic Rectopexy with Mesh

Speaker(s) : Bradley Davis, MD, Cincinnati, OH

Video Sessions

Objectives :

______________________

Colonoscopic High Frequency Ultrasound as Useful Adjunct during Routine Colonoscopy
Disclosure: No Affiliation

Speaker(s) : A. Haji, S. Papagrigoriadis, London, UK


______________________

Robotic Total Mesorectal Excision in Severely Obese Female Patient
Disclosure - No: Affiliation

Speaker(s) : T. Edson, Park Ridge and Chicago, IL, S. Marecik, J. Park, L. Prasad


______________________

Acquiring Basic Skills for Robotic TME on Pelvic Simulator
Disclosure: No Affiliation

Speaker(s) : J. Blumetti, S. Marecik, B. Paris, Park Ridge and Chicago, IL, L. Prasad


______________________

Robotic Total Mesorectal Excision in Obese Male Patient
Disclosure: No Affiliation

Speaker(s) : T. Edson, Park Ridge and Chicago, IL, S. Marecik, J. Park, L. Prasad


______________________

Combined Laparoscopy and CO2 Colonoscopy for Polyp Removal
Disclosure: No Affiliation

Speaker(s) : V. Ho, S. Lee, J. Milsom, New York, NY, T. Sonoda, S. Stein, J. Yan


______________________

Restorative Procto Sigmoidectomy for Giant Villous Tumor – A Combined Laparoscopic and Perineal Approach
Disclosure: No Affiliation

Speaker(s) : A. Dagan, Jerusalem, Israel, P. Reissman


______________________

Laparoscopic Subtotal Colectomy and Rectopexy (HALS)
Disclosure: No Affiliation

Speaker(s) : R. Khoo, Santa Rosa, CA


______________________

Laparoscopic Repair of Postabdominoperineal Resection Perineal Hernia
Disclosure: Raven Technologies – Research Grant (Principal Investigator)

Speaker(s) : M.A. Abbas, A. Kwok, V. Nguyen, Los Angeles, CA


______________________

The Laparoscopic Management of Early Postoperative Small Bowel Obstruction
Disclosure: Genzyme – Honorarium (Speakers Bureau); W. L. Gore – Honorarium (Teaching and Mentoring in the O.R.)

Speaker(s) : Z. Awad, E. Lambert, Jacksonville, FL


______________________

Robotic Resection of a Presacral Mass
Disclosure: No Affiliation

Speaker(s) : S. Celinski, S. Chalikonda, Pittsburgh, PA, M. Holtzman, A. Mavanur


______________________

Transanal Hemorrhoidal Dearterialization – Procedure for Hemorrhoids and Hemorrhoidal Prolapse
Disclosure: THD America – Honorarium (Trainer)

Speaker(s) : M. Page, Des Moines, IA


______________________

Robotic Right Colectomy
Disclosure: No Affiliation

Speaker(s) : A. Cha, D. Crawford, Peoria, IL, S. Tsoraides


______________________

Laparoscopic Total Mesorectal Excision for Rectal Cancer
Disclosure: No Affiliation

Speaker(s) : C. Heise, Madison, WI, G. Kennedy


______________________

Double Port Laparoscopic-assisted Ileal Pouch Anal Anastomosis
Disclosure: No Affiliation

Speaker(s) : M. Alban, P. Fleshner, Los Angeles, CA , M. Gaon, Z. Murrell


______________________

Transanal Single Port Low Anterior Resection
Disclosure: No Affiliation

Speaker(s) : A. Fajardo, J. Fleshman, S. Hunt, M. Mutch, St. Louis, MO


______________________

Laparoscopic-assisted Natural Orifice Surgery: Transvaginal Sigmoidectomy and Rectocolpopexy
Disclosure: No Affiliation

Speaker(s) : J. Frattini, B. Krieger, J. Marcet, Tampa, FL, S. Rasheid, J. Sanchez


______________________

Martius Procedure for Complex Rectal and AnoVaginal Fistula
Disclosure: No Affiliation

Speaker(s) : B. Gurland, T. Hull, Cleveland, OH, M. Zutshi


______________________

Overlapping Sphincter Repair with Tissue Augmentation
Disclosure: No Affiliation

Speaker(s) : K. Garrett, B. Gurland, T. Hull, Cleveland, OH, M. Zutshi


______________________

Laparoscopic Very Low Stapling in Ileal Pouch Anal Anastomosis for Benign Disease
Disclosure: Ethicon Endo Surgery – Consulting Fee (Consultant, Speaker)

Speaker(s) : S. Berdah, D. Birnbaum, Marseille, France


______________________

Cleft Lift Treatment for Unhealed Pilonidal Disease
Disclosure: MISDER, LLC – Ownership Interest (Founder, Chairman of Board); AMI (Agency for Medical Innovations) – Honorarium (Instructor); Ethicon EES – Honorarium (Instructor/Consultant); American Physicians Instit. for Adv. Prof. Studies – Honorarium (Instructor)

Speaker(s) : M. Brand, Chicago, IL

Contact Us : info@dcprovidersonline.com
(630) 963-8311 - Digital Conference Providers, Inc. - 1081 Zygmunt Circle - Westmont, IL 60559